MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1507/endocrj.ej22-0241

Медицинская библиотека · Endocrine journal · 2022

Self-reported symptoms in patients with acromegaly: a 6-month follow-up in a single neurosurgical center.

Lin Ben, He Wenqiang, Chen Zhengyuan, Shen Ming, Shou Xuefei, Chen Long, Ma Zengyi, Wang Yongfei

СтатьяПеревод пока не подготовлен

Аннотация

Acromegaly is characterized by hypersecretion of growth hormone (GH) and insulin-like growth factor 1 (IGF-1), accompanied by a compromise in the perception of wellness. The Patient-Assessed Acromegaly Symptom Questionnaire (PASQ) is relevant to assessing signs and symptoms but is mainly used to evaluate the efficacy of a pharmacological intervention. To explore the perioperative variation in symptom severity, the divergence between subgroups stratified according to clinical outcomes or treatment modalities, and the interaction between symptom scores and clinical indices, we prospectively recruited 106 patients with acromegaly from 2016 to 2018. Oral glucose tolerance and GH tests were performed, and PASQ was administered before treatment and 6 months postoperatively. Patients were divided into active (n = 49) and remission (n = 57) groups according to postoperative GH and IGF-1 levels. PASQ scores and GH and IGF-1 levels decreased significantly postoperatively in both groups. A significantly higher preoperative headache score and greater extent of decrease in arthralgia were seen in the active and remission groups, respectively. No significant variation in PASQ scores was found between patients receiving surgery alone and those receiving preoperative somatostatin analogs. Preoperative fasting GH (GH0) levels were positively correlated with preoperative excessive perspiration. Further regression analyses validated the variation in GH0 as a noteworthy determinant of the extent of change in soft-tissue swelling, excessive perspiration, fatigue, and total PASQ scores. Patient-reported symptoms were substantially alleviated after surgery, independent of endocrine remission or use of preoperative somatostatin. A GH level decrease was a notable coefficient for PASQ scores.

Для цитирования: Lin Ben, He Wenqiang, Chen Zhengyuan, Shen Ming, Shou Xuefei, Chen Long, Ma Zengyi, Wang Yongfei. Self-reported symptoms in patients with acromegaly: a 6-month follow-up in a single neurosurgical center.. Endocrine journal. 2022. DOI: 10.1507/endocrj.ej22-0241.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.